Article in Infection and immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
5 citing papers in PubMed, 7 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 5 institutions in 3 countries.
Elena Dudukina *Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Laura de Smit *Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Giel J A Verhagen *Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Arie van de EndeAmsterdam UMC, University of Amsterdam, Department of Medical Microbiology and Infection Prevention and the Netherlands Reference Laboratory for Bacterial Meningitis, Amsterdam, the Netherlands.ORCID 0000-0003-1298-3086
José María MarimónBiodonostia, Infectious Diseases Area, Respiratory Infection and Antimicrobial Resistance Group, Osakidetza Basque Health Service, University Hospital Donostia, San Sebastian, Basque Country, Spain.ORCID 0000-0002-2787-7094
Paula Bajanca-LavadoDepartment of Infectious Disease, National Institute of Health, Lisbon, Portugal.ORCID 0000-0002-1453-0315
Carmen ArdanuyMicrobiology Department, Hospital Universitari de Bellvitge, Universitat de Barcelona-IDIBELL, Barcelona, Spain.ORCID 0000-0003-0225-607X
Sara MartiMicrobiology Department, Hospital Universitari de Bellvitge, Universitat de Barcelona-IDIBELL, Barcelona, Spain.ORCID 0000-0002-0405-2305
Marien I de JongeSection Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID 0000-0003-2812-5895
Jeroen D LangereisSection Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands jeroen.langereis@radboudumc.nl.ORCID 0000-0001-5317-3202
Radboud University Nijmegen · NLInstituto de Salud Carlos III · ESAmsterdam University Medical Centers · NLBiogipuzkoa Health Research Institute · ESNational Institute of Health Dr. Ricardo Jorge · PT
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdultAgedComplement ActivationComplement System ProteinsEuropeFemaleHaemophilus InfectionsHaemophilus influenzaeHumansImmune EvasionImmunoglobulin GImmunoglobulin MMaleMicrobial ViabilityMiddle AgedSerumComplement System ProteinsImmunoglobulin GImmunoglobulin Mbacteremiacomplement evasionHaemophilus influenzaeIgGIgMmeningitissepsis
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Antibody Binding and Complement-Mediated Killing of Invasive Haemophilus influenzae Isolates from Spain, Portugal, and the Netherlands. · full record | OpenQuestion